Mina Jacob
Vascular Surgery · Mobile, ALNPI 1730132556
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.9%), travel and lodging and other — rather than concentrated in one kind of arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 23.1%. 2025 is the largest year on record at $5,579, 4.8 times the $1,151 reported in 2019.
Across 298 payments — averaging $65.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$4K
- Medtronic$3K
- Angiodynamics, Inc.$2K
- Abbott$2K
- Boston Scientific$2K
- Pfizer$655
- plus $5K from 34 others
Across 1 payment — averaging $2000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$2K
What the payments were for
- Consulting fees$3002%
- Travel & lodging$5,48628%
- Food & beverage$11,24758%
- Other$2,40012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 22 | $4,495 |
| Medtronic(2 entities) | 31 | $2,818 |
| Angiodynamics, Inc. | 2 | $2,422 |
| Abbott | 14 | $2,257 |
| Boston Scientific | 32 | $1,612 |
| Pfizer | 34 | $655 |
| Novartis | 35 | $623 |
| Inari Medical, Inc. | 5 | $502 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 25 | $457 |
| Siemens Medical Solutions USA, Inc. | 7 | $392 |
| Penumbra, Inc. | 7 | $317 |
| Covidien LP | 1 | $300 |
| Abiomed | 3 | $268 |
| Veryan Medical Incorporated | 3 | $265 |
| E.r. Squibb & Sons, L.L.C. | 6 | $203 |
| Amgen | 7 | $192 |
| Johnson & Johnson | 13 | $184 |
| GE HealthCare | 2 | $172 |
| Boehringer Ingelheim | 11 | $166 |
| Actelion Pharmaceuticals US, Inc. | 2 | $141 |
| Shockwave Medical, Inc | 3 | $135 |
| Silk Road Medical, Inc. | 1 | $132 |
| Alnylam Pharmaceuticals Inc. | 4 | $117 |
| Baxter Healthcare | 2 | $90 |
| Sanofi-aventis U.S. LLC | 4 | $76 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $68 |
| Philips North America LLC | 2 | $63 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $42 |
| Stryker | 1 | $37 |
| Bayer | 2 | $33 |
| Biosense Webster, Inc. | 1 | $31 |
| Merck | 2 | $30 |
| Esperion Therapeutics, Inc. | 1 | $25 |
| AstraZeneca | 2 | $25 |
| GSK | 1 | $21 |
| Elutia, Inc. | 1 | $16 |
| Terumo Medical Corporation | 1 | $15 |
| Portola Pharmaceuticals, LLC | 1 | $14 |
| Argon Medical Devices, Inc. | 1 | $14 |
| Acutus Medical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaCure 1470 Pro$2,400
- COREVALVE EVOLUT R$1,887
- PASCAL$1,222
- Edwards SAPIEN 3 Transcatheter Heart Valve$986
- FLOWTRIEVER CATHETER, S$480
- CT THROMBECTOMY SYSTEM KIT$480
- GENERAL - STRUCTURAL HEART$344
- MitraClip$327
- Indigo System$249
- BioMimics 3D Vascular Stent System$246
- Watchman$242
- ACUSON Origin Diagnostic Ultrasound System$171
- AMPLATZER AMULET$168
- EVOQUE$153
- CoreValve Evolut$138
- Artis icono floor$136
- ENROUTE Transcarotid Stent$132
- ENROUTE .014 Guidewire$132
- ENROUTE Transcarotid Neuroprotection System$132
- ENHANCE Transcarotid Peripheral Access Kit$132
How this compares
$19,433 in reported general payments places this provider in the 85th percentile of 61 vascular surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 366 | $317,309 |
| EntrestoSacubitril/Valsartan | 97 | $95,116 |
| XareltoRivaroxaban | 107 | $93,610 |
| BrilintaTicagrelor | 43 | $26,464 |
| Repatha SureclickEvolocumab | 28 | $21,767 |
| ClopidogrelClopidogrel Bisulfate | 766 | $8,398 |
| Atorvastatin Calcium | 395 | $4,561 |
| Prasugrel Hcl | 64 | $3,636 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 63 | $3,448 |
| Valsartan | 128 | $3,383 |
| Metoprolol Succinate | 215 | $2,707 |
| Carvedilol | 287 | $2,446 |
| Nebivolol Hcl | 25 | $1,991 |
| Isosorbide Dinitrate | 27 | $1,967 |
| Ezetimibe | 67 | $1,763 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $655 | $317,309366 claims |
| NovartisEntresto | $623 | $95,11697 claims |
| Johnson & JohnsonXarelto | $184 | $93,610107 claims |
| AstraZenecaBrilinta | $25 | $26,46443 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 61 vascular surgery providers in Alabama.
Other vascular surgery in Mobile
- Benjamin MakamsonMobile$18K
- Lee FergusonMobile$13K
- Cullen McCarthyMobile$8K
- Glenn EssesMobile$7K
- Michael DoMobile$7K
- Lewis LyonsMobile$6K
- William HardyMobile$3K
- Melanie RoseMobile$3K
- Ralph PfeifferMobile$2K
- Albert PacificoBirmingham$5.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.